drugset / Trial / NCT01586117

A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity

NCT01586117

Phase 2 Unknown 40 enrolled Chinese Academy of Medical Sciences
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the effect of intrarectal Amifostine administration on acute radiation-induced rectal toxicity in pre-operative chemo-radiotherapy.

Timeline

Start
2012-02
Primary completion
2013-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject amifostine Unknown 1500 mg Other

Indications